Interestingly, the DEFINE-HF study [83] assessed 263 patients randomized to a treatment with 10 mg dapagliflozin daily vs. a placebo for 12 weeks and evaluated the changes in NT-proBNP. This evidence concerns the gene NPPB and hydrops fetalis.